Tower Research Capital (TRC)’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $542K | Buy |
31,888
+16,935
| +113% | +$288K | 0.01% | 914 |
|
2025
Q1 | $292K | Buy |
14,953
+13,581
| +990% | +$265K | 0.01% | 1158 |
|
2024
Q4 | $34K | Sell |
1,372
-5,172
| -79% | -$128K | ﹤0.01% | 2813 |
|
2024
Q3 | $160K | Sell |
6,544
-21,819
| -77% | -$535K | ﹤0.01% | 1825 |
|
2024
Q2 | $665K | Buy |
28,363
+22,319
| +369% | +$523K | 0.01% | 1086 |
|
2024
Q1 | $200K | Sell |
6,044
-218
| -3% | -$7.2K | ﹤0.01% | 1413 |
|
2023
Q4 | $170K | Buy |
6,262
+2,168
| +53% | +$59K | ﹤0.01% | 2231 |
|
2023
Q3 | $98.5K | Sell |
4,094
-7,325
| -64% | -$176K | ﹤0.01% | 1990 |
|
2023
Q2 | $365K | Buy |
11,419
+5,759
| +102% | +$184K | 0.01% | 1167 |
|
2023
Q1 | $173K | Buy |
5,660
+4,090
| +261% | +$125K | 0.01% | 1448 |
|
2022
Q4 | $61K | Sell |
1,570
-32,893
| -95% | -$1.28M | ﹤0.01% | 2188 |
|
2022
Q3 | $1.64M | Buy |
34,463
+10,281
| +43% | +$490K | 0.03% | 495 |
|
2022
Q2 | $936K | Buy |
24,182
+1,433
| +6% | +$55.5K | 0.02% | 735 |
|
2022
Q1 | $1.3M | Buy |
22,749
+20,059
| +746% | +$1.15M | 0.01% | 701 |
|
2021
Q4 | $215K | Sell |
2,690
-1,626
| -38% | -$130K | ﹤0.01% | 1708 |
|
2021
Q3 | $376K | Buy |
4,316
+2,121
| +97% | +$185K | 0.01% | 1195 |
|
2021
Q2 | $283K | Sell |
2,195
-19,370
| -90% | -$2.5M | 0.01% | 1642 |
|
2021
Q1 | $1.73M | Buy |
21,565
+18,075
| +518% | +$1.45M | 0.03% | 535 |
|
2020
Q4 | $285K | Sell |
3,490
-14,349
| -80% | -$1.17M | 0.01% | 1431 |
|
2020
Q3 | $439K | Buy |
17,839
+15,225
| +582% | +$375K | ﹤0.01% | 1824 |
|
2020
Q2 | $73K | Buy |
+2,614
| New | +$73K | ﹤0.01% | 2739 |
|